ASKA Pharmaceutical Co.,Ltd. 4514Short Interest
No institution currently reports a short position of 0.5% or more in ASKA Pharmaceutical Co.,Ltd. (4514). The last disclosure was on 2019-12-24 (J.P. MORGAN SECURITIES PLC, 0.01%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
2 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 1 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2019-12-18 |
|---|---|
| Latest disclosure | 2019-12-24 (J.P. MORGAN SECURITIES PLC, 0.01%) |
| Reporting institutions | 1 firms (2 reports) |
| Peak estimated short interest | 0.56% (2019-12-18, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
No position of 0.5% or more reported within a year existed in the last 5 years, so no chart is shown. Past disclosures are listed in the tables below.
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2019-12-24 | J.P. MORGAN SECURITIES PLC | Position 4,993 shares | Ratio 0.01% | ▼0.55% | Below 0.5% |
Disclosure History 2 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2019-12-24 | J.P. MORGAN SECURITIES PLC | Position 4,993 shares | Ratio 0.01% | ▼0.55% | Below 0.5% |
| 2019-12-18 | J.P. MORGAN SECURITIES PLC | Position 174,100 shares | Ratio 0.56% | ▲0.19% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |